Wessel P Brouwer

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. doi The development of familial hypertrophic cardiomyopathy: from mutation to bedside
    Wessel P Brouwer
    Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Clin Invest 41:568-78. 2011
  2. doi Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers
    Wessel P Brouwer
    Department of Cardiology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    Eur Heart J Cardiovasc Imaging 13:292-7. 2012
  3. doi Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy
    Mohamed F A Aly
    Department of Cardiology 5F 003, Institute for Cardiovascular Research ICaR VU, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Int J Cardiovasc Imaging 30:523-33. 2014
  4. pmc In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
    Wessel P Brouwer
    Department of Cardiology, ICaR VU, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands
    J Cardiovasc Magn Reson 16:28. 2014
  5. doi Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction
    Stefan A J Timmer
    Department of Cardiology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    Eur J Heart Fail 13:1283-9. 2011
  6. doi Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function
    Sebastiaan A Kleijn
    Department of Cardiology 5F 003, Institute for Cardiovascular Research ICaR VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Eur Heart J Cardiovasc Imaging 13:834-9. 2012
  7. ncbi Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management
    Constantin B Marcu
    Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    Conn Med 75:581-90. 2011

Collaborators

Detail Information

Publications7

  1. doi The development of familial hypertrophic cardiomyopathy: from mutation to bedside
    Wessel P Brouwer
    Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Clin Invest 41:568-78. 2011
    ..Additionally, present and future therapeutic options will be briefly discussed...
  2. doi Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers
    Wessel P Brouwer
    Department of Cardiology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    Eur Heart J Cardiovasc Imaging 13:292-7. 2012
    ..Finally, we evaluated the accuracy of crypts to identify carriers in HCM family screening...
  3. doi Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy
    Mohamed F A Aly
    Department of Cardiology 5F 003, Institute for Cardiovascular Research ICaR VU, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Int J Cardiovasc Imaging 30:523-33. 2014
    ..Further research in a larger study population with gene-specific analysis is warranted for potential clinical usefulness of 3DSTE in family screening for HCM...
  4. pmc In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
    Wessel P Brouwer
    Department of Cardiology, ICaR VU, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands
    J Cardiovasc Magn Reson 16:28. 2014
    ..We hypothesized that with T1 mapping, which is employed to determine the myocardial extracellular volume fraction (ECV), can detect diffuse interstitial fibrosis in HCM patients...
  5. doi Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction
    Stefan A J Timmer
    Department of Cardiology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    Eur J Heart Fail 13:1283-9. 2011
    ..Therefore, the aim was to investigate myocardial perfusion and energetics in genotype-positive, phenotype-negative HCM subjects (carriers)...
  6. doi Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function
    Sebastiaan A Kleijn
    Department of Cardiology 5F 003, Institute for Cardiovascular Research ICaR VU, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Eur Heart J Cardiovasc Imaging 13:834-9. 2012
    ....
  7. ncbi Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management
    Constantin B Marcu
    Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    Conn Med 75:581-90. 2011
    ..Judicious use of various diagnostic modalities such as serum markers and imaging studies, and good communication among all the physicians involved in the care of these sick and frail patients, are keys to a better outcome...